30/04/2024 - Institutional news
Researchers from the Neuroscience Research Program, in conjunction with the University of Minnesota in the United States, will conduct the first meta-analysis with individual data on this issue. They will analyze data from more than 30,000 people in the United States and four European countries. The aim is to obtain recommendations so that governments can establish dietary guidelines to prevent the onset of diseases such as Alzheimer's disease. Is there any type of diet that really works to prevent cognitive decline? Despite all the publications on this question, the scientific evidence is not conclusive. For this reason, the Institute for the Advancement of Foord and Nutrition Sciences (IAFNS), in the United States, a body that acts as an advisor to the US government, has commissioned the Hospital del Mar Research Institute and the Epidemiology and Community Health Division of the University of Minnesota School of Public Health to conduct the first meta-analysis with individual data on the question.
19/04/2024 - General information
He is one of the four runner-ups awarded. He won it for his research in the field of neuroscience and cannabinoid drugs. Dr. Arnau Busquets, coordinator of the Cellular Mechanisms in Physiological and Pathological Behavior Research Group at the Hospital del Mar Research Institute, has won one of the runner-up awards at the 60th Anniversary Farmaindustria Young Researchers Prize. The winner of the prize was Cristina Mayor-Ruiz, from the Biomedical Research Institute of Barcelona. The awards were presented on April 18 at the Círculo de Bellas Artes in Madrid.
15/04/2024 - General information
The Reial Acadèmia de Medicina de Catalunya chose, in a plenary session held on April 9, Dr. Manuel Pera as the new full academician of the institution. Dr. Pera, who was already a corresponding academic since 2022, will be attached to the surgery section of the institution. The section chief of the Gastrointestinal Surgery Unit of the Hospital del Mar and researcher at the center's Research Institute, thus becomes one of the sixty full academicians of the institution. The election is made by a vote among the members themselves. The ceremony of entry into the Royal Academy will take place in the coming months.
11/04/2024 - Press release
It has received a grant from the Carlos III Health Institute to be part of the ISCIII platform for the dynamization and innovation of the industrial capacities of the National Health Service. The project of the Innovation and Digital Transformation Unit presented by the Hospital del Mar research institute on the ITEMAS platform for the dynamization and innovation of the industrial capacities of the National Health Service of the Carlos III Health Institute (ITEMAS ISCIII) will receive a grant of about 300.000 euros for its development in the period 2024-2026. The initiative, coordinated by the Parc Taulí Research and Innovation Institute (I3PT), will have 26 innovation support units and more than a hundred collaborators throughout the State.
09/04/2024 - Press release
A two-year project funded by the EU Horizon 2020 program Protecting mental health in times of change. Santa Coloma de Gramenet will host a large-scale European project, MENTBEST, starting from September 2024, led by Dr. Benedikt Amann from Hospital del Mar Barcelona. The project aims to address suicide prevention and the reduction of depression and emotional distress in communities undergoing rapid transformation in a community-based approach.
Més informació "The MENTBEST Project kicks off in Santa Coloma de Gramenet."
05/04/2024 - Press release
Their application must be individualized and monitored by specialists in Physical Medicine and Rehabilitation, as well as in mental health The reviewed studies agree on the benefits of physical exercise in returning to pre-depression functionality, improving depressive symptoms, and enhancing the quality of life of patients This is indicated by the first systematic review of the scientific literature on depressive symptoms and functionality, published in the Journal of Affective Disorders
Més informació "Exercise programs can improve depressive symptoms"
22/03/2024 - Press release
Having a higher biological or epigenetic age, which differs from chronological age and is influenced by lifestyle habits and external environmental factors, increases the risk of death in patients treated for a subarachnoid hemorrhage. Conversely, having a lower biological age increases the likelihood of experiencing one of the most common complications in these cases, the spasm of the cerebral arteries, known as vasospasm. This is the first time this relationship can be demonstrated, opening the door to research on how these factors can be modified to improve patient prognosis.
14/03/2024 - Press release
An international study published in Science Translational Medicine involving the Hospital del Mar Research Institute and the Vall d'Hebron Research Institute shows that there are substantial differences between men and women in the energy metabolism of renal tubular cells. In men with diabetes, more markers of oxidative stress in cells and processes linked to cell death are detected, which may predispose to diabetic nephropathy. The work may provide tools to personalize the treatment and evolution of people with diabetes and kidney disease, as well as to detect possible therapeutic targets based on this fact.
Més informació "Renal cell metabolism in diabetic men predisposes to renal disease"
13/03/2024 - Press release
The institution's Governing Council has approved the appointment of Dr. Raventós, who had already been manager of the institution between 2008 and 2011. He will take over the position from April 1 from Dr. Olga Pané, who has been manager for the last twelve years. The Governing Council of Consorci Mar Parc de Salut (Hospital del Mar) has approved the appointment of Dr. Jaume Raventós as the new manager of the institution. Dr. Raventós will replace Dr. Olga Pané as of April 1 due to her retirement. Dr. Pané has held the position of manager between 2011 and the present.
11/03/2024 - Covid-19
This is revealed by a study at Hospital del Mar, which prospectively analyzed data from nearly 2,000 people followed at the center's Post-COVID Unit. The main risk factors for developing persistent COVID are obesity, asthma and the severity of the disease. Women are also at higher risk These results lead the authors of the study to consider antiviral treatment also for people with SARS-CoV-2 infection who meet these risk factors, even if they do not suffer from severe COVID.
Més informació "Treatment of COVID-19 with antivirals may protect from persistent COVID"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
